Biomonitoring of Internal Exposure to MNPLs, and Its Effects, in Blood of Patients With Chronic Kidney Disease (CKD)

Inclusion Criteria17

• Participant submitted to hemodialysis for more than 3 months
• Between 18 and 85 years old
• Stable haemoglobin (more than 10 gr/dl)
• Absence of infectious disease at the date of sample collection and for a period of more than two weeks
• Absence of active neoplasia
• Stable vascular access
• No hemodialysis treatment
• Between 18 and 85 years old
• Stable haemoglobin (more than 10 gr/dl)
• Glomerular filtration ≤ 20 ml/min
• Absence of infectious disease at the date of sample collection and for a period of more than two weeks
• Absence of active neoplasia
• Between 18 and 85 years old (paired by gender, age and lifestyle to the CKD patients)
• Absence of chronic kidney disease or dialysis treatment
• Absence of chronic pathology (including neoplasia)
• Absence of infectious disease at the date of sample collection and for a period of more than two weeks
• Spanish residence